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Abstract
Background: Analysis of factors contributing to high affinity antibody-protein interactions provides insight into
natural antibody evolution, and guides the design of antibodies with new or enhanced function. We previously
studied the interaction between antibody D5 and its target, a designed protein based on HIV-1 gp41 known as
5-Helix, as a model system [Da Silva, G. F.; Harrison, J. S.; Lai, J. R., Biochemistry, 2010, 49, 5464–5472]. Antibody D5
represents an interesting case study because it is derived from the VH1-69 germline segment; this germline
segment is characterized by a hydrophobic second heavy chain complementarity determining region (HCDR2)
that constitutes the major functional paratope in D5 and several antibodies derived from the same progenitor.
Results: Here we explore side chain requirements for affinity and specificity in D5 using phage display. Two
D5-based libraries were prepared that contained diversity in all three light chain complementarity determining
regions (LCDRs 1–3), and in the third HCDR (HCDR3). The first library allowed residues to vary among a restricted
set of six amino acids (Tyr/Ala/Asp/Ser/His/Pro; D5-Lib-I). The second library was designed based on a survey of
existing VH1-69 antibody structures (D5-Lib-II). Both libraries were subjected to multiple rounds of selection against
5-Helix, and individual clones characterized. We found that selectants from D5-Lib-I generally had moderate affinity
and specificity, while many clones from D5-Lib-II exhibited D5-like properties. Additional analysis of the D5-Lib-II
functional population revealed position-specific biases for particular amino acids, many that differed from the
identity of those side chains in D5.
Conclusions: Together these results suggest that there is some permissiveness for alternative side chains in the
LCDRs and HCDR3 of D5, but that replacement with a minimal set of residues is not tolerated in this scaffold for
5-Helix recognition. This work provides novel information about this high-affinity interaction involving an antibody
from the VH1-69 germline segment.

Background
Specific and high affinity antibody-antigen interactions
are critical to humoral immunity. Understanding
antibody-antigen structure-function relationships provides basic information about molecular recognition and
can aid in development of new research and therapeutic
reagents [1-4]. We previously studied the interaction between the HIV-1 antibody D5 and its target (a protein
mimic of HIV-1 gp41 known as ‘5-Helix’) as a model
system for antibody-protein recognition (Figure 1a)
[5-7]. This interaction has several unique characteristics.
* Correspondence: jon.lai@einstein.yu.edu
Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris
Park Avenue, Bronx, NY 10461, USA

D5 has very high affinity for 5-Helix despite the fact that
it was not evolved against this target (i.e., D5 was
obtained from a ‘naïve’ phage antibody library) and the
heavy and light chains are not heavily mutated relative
to germline sequences [6,7]. The reported KD values of
D5 range from 50 pM to 20 nM, depending on the
measurement technique (surface plasmon resonance,
SPR, vs. isothermal titration calorimetry, ITC) and on
the fragment (single-chain variable fragment, scFv, vs.
antigen binding fragment, Fab, vs. IgG) [6-9]. In general,
antibodies that bind proteins with high affinity contain
extensively mutated (i.e., evolved) complementarity determining regions (CDRs); therefore, the lower mutation
rate of D5 suggests that some naïve antibodies may
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Figure 1 Structure of the D5-5-Helix interaction and similarities to CR6261. (a) Crystal structure of the D5-5-Helix complex reported by
Luftig et al. (ref. 6, PDB ID 2CMR). The D5 light chain is colored in red, the D5 heavy chain in blue, and 5-Helix in yellow; side chains of residues
involved in the interface are shown in stick. The critical HCDR2 is boxed. (b) Similarity of interactions involving HCDR2 in D5 and CR6261 (ref. 11,
PDB ID 3GBN). In both antibody-antigen complexes, F54 of HCDR2 (a germline-encoded residue) inserts into a hydrophobic cleft on the antigen
(here, shown in gray). The amino acid sequence of HCDR1 and HCDR2 regions from VH1-69, D5, and CR6261 are also shown. (c) Cross-reactivity
analysis of phage clones displaying the bivalent scFv (biv-scFv) of D5 and CR6261. Phage titers were ~ 1012 infectious units/mL for both clones.

have properties of evolved antibodies. Formation of the
D5-5-Helix interface results in burial of > 1000 Å2 of
combining site surface and residues in all six CDRs are
involved in direct contacts with 5-Helix [6]. Most other
antibody-antigen interactions are dominated by residues
in heavy chain CDRs (HCDRs). Finally, the D5 heavy
chain is derived from the VH1-69 germline segment and
the HCDR1 and HCDR2 regions are identical to the
germline. A striking similarity exists between the
HCDR2-dominated interactions of D5 and those of another VH1-69 antibody, CR6261, which targets influenza
HA (Figure 1b) [6,10-15]. The HCDR2 sequence and
backbone conformations are highly similar, and in both
cases the critical feature of the recognition involves insertion of F54 (a germline-encoded HCDR2 residue) into
a hydrophobic cleft on the antigen [6,11]. Interestingly,
while the HCDR1 regions are highly similar between
both antibodies, an S30R mutation in CR6261 was
shown to be a specificity determinant in its interaction
with HA [14]. These results suggest that, while the

hydrophobic HCDR2 may serve as a critical anchor
point to engage in antigen recognition, other regions
could play an important role in specificity determination.
We previously reported that light chain contacts in D5
play an important role in affinity for 5-Helix [5].
A growing body of work has deciphered the rules
for molecular recognition by antibodies and other
immunoglobulin-like scaffolds. Recent efforts have focused on developing libraries containing restricted diversity segments within the CDRs of stable heavy and light
chain variable domain (VH and VL, respectively) frameworks [16-21]. This diversity is encoded by designed,
synthetic oligonucleotides (‘synthetic antibodies’) which,
when used in combination with screening by a display
method (e.g., phage display, yeast display, or mRNA display), allows for identification of antibodies or antibody
fragments with specificities and affinities comparable to
or better than antibodies obtained from natural sources
[22-26]. Additionally, restricted diversity libraries permit
high-throughput mutagenesis studies of combining site
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residues to determine which characteristics most accurately reflect the physicochemical attributes of functional
antibodies [4,16-18]. As an example, libraries in which residues at the CDRs are allowed to vary among subsets of
amino acids (in some cases as few as two – Tyr and Ser)
yield high affinity and specific binders in the context of
regular immunoglobulin scaffolds and single-domain variants [4,16]. These results highlight the versatility of the
immunoglobulin scaffold for molecular recognition.
Here we examine the factors that contribute to affinity
and specificity of D5 by phage display using 5-Helix as a
model antigen. The germline-encoded HCDR2 is believed to represent a critical feature of VH1-69 antibody
recognition, as reflected in the apparent similarities in
HCDR2 interactions between D5, CR6261, and others
[6,10,14,15]. Therefore, we created two D5-based phage
display libraries, in which the HCDR3 and the light
chain (LCDRs) were allowed to vary using two different
randomization schemes. We evaluated the abilities of
these two libraries to specifically recognize 5-Helix with
high affinity. This study provide insights into aspects of
antibody recognition by the VH1-69 germline.

Results
Specificity Profiles of D5 and CR6261

Given the similarity of HCDR1 and HCDR2 among D5,
CR6261 and the common VH1-69 germline segment
[6,11-15], we sought to explore the degree of specificity of
these two antibodies toward their native antigens. We
expressed the single chain variable fragments (scFv) for
both D5 and CR6261 in bivalent format on the surface of
M13 bacteriophage as a fusion to the major coat protein
pIII. Binding was tested against both 5-Helix and the
CR6261 target HA. As shown in Figure 1c, both antibodies
displayed high specificity toward their native antigens.
Library design

We wondered to what degree the specificity and affinity
in D5 was governed by CDRs other than HCDR1 and
HCDR2 (LCDRs 1–3, and HCDR3). To explore this
question, we designed and produced two synthetic antibody libraries based on D5 (these libraries are shown in
Table 1). In Library I (D5-Lib-I), we introduced variation
such that surface-exposed LCDR positions and residues

in HCDR3 were permitted to vary in hexanomial fashion
among Ala, Asp, Ser, Tyr, His and Pro (the ‘BMT’ codon
was used where B = C/G/T, M = A/C). Synthetic antibody libraries containing binomial (Tyr/Ser) or tetranomial
(Ala/Asp/Tyr/Ser) codon sets have been successful against
many antigens in the context of other germline scaffolds
[16-19,26]. The hexanomial scheme explored here also includes the positively-charged His and the conformationallyrestricted Pro.
In the second library (Library II, D5-Lib-II), variation
in the LCDRs was designed to mimic diversity of natural
antibodies derived from the VH1-69 germline and paired
with VΚ light chains. We queried the PDB to identify
antibodies with high homology to the VH1-69 germline
segment that fulfilled three criteria: (1) their threedimensional structures had been solved in complex with
the antigen; (2) the antibody represented a product or
variant of natural rearrangement (i.e., antibodies
resulting from synthetic repertoires were not considered); (3) the sequences were unique. We compiled sequences from 24 total antibodies and found that 18 of
these contained VK light chains (see Additional file 1:
Table S1). These antibodies target a variety of antigens
(including small molecules, peptides, and proteins), and
were isolated from phage display and other sources. In
general, the LCDR loop lengths among these antibodies
were similar to those found in D5. We examined each of
the crystal structures and assessed LCDR positions for
their importance in the structural paratope as gauged by
surface area buried upon complex formation (Table 2).
We assigned a qualitative ‘contact score’ (low, mid, or
high) at each position based on the extent to which the
residue at that position participated in structural
paratopes across the datasets. In general, those positions
with ‘high’ contact score contained side chains in which
> 80% of the surface area was buried upon binding in
three or more complexes. We determined the amino
acid distribution at each position and designed restricted
diversity codons to allow composition that reflected the
distribution at each position or, in some cases, residues
that had similar physicochemical properties to the natural distribution. At several positions, we allowed greater
diversity than was observed in the structural dataset. For
HCDR3, we allowed variation among the 12 residues

Table 1 Library design
Amino acid substitutionsA
Library
D5-Lib-I
D5-Lib-II

LCDR1B (D5 WT permitted)
A/D/H/P/S/Y
C

Tailored

LCDR2

HCDR3B (D5 WT permitted)

LCDR3

A/D/H/P/S/Y
C

Tailored

A/D/H/P/S/Y
C

Tailored

A/D/H/P/S/Y
A/C/D/E/G/K/N/R/S/T/Y/W

Theoretical diversity

Actual diversity

17

3 x 109

19

3 x 109

8 x 10
8 x 10

A
Amino substitutions encoded by limited diversity codon sets. For LCDRs 1 – 3: BMT (D5-Lib-I), or tailored codon sets listed in Table 2 (D5-Lib-II); for HCDR3 in all
libraries: DVK. Nucleotide degeneracies: M = A/C, B = C/G/T, D = A/G/T, V = A/C/G, K = G/T.
B
In LCDR1 and HCDR3, the library synthesis was performed in such a manner to allow the D5 WT sequence as an alternative to the library sequences.
C
Tailored diversity codon sets used as shown in Table 2.

Stewart et al. BMC Biochemistry 2013, 14:9
http://www.biomedcentral.com/1471-2091/14/9

Page 4 of 15

Table 2 Library design
Contact scoreA

Amino acid distribution (frequency)B

Designed codonC

Encoded residues (coverageD)

E27

Low

E(3)/Q(13)/S(2)

Not varied

E (17%)

G28

Mid

D*(5)/G(2)/N(1)/Q(1)/S(8)/Y*(1)

RRC

D/N/G/S (88%)

Y30

Mid

G(3)/R(1)/S*(10)/Y*(2)/V(1)

NDT

C/D/F/G/H/I/N/L/R/S/V/Y (100%)

H31

Mid

H(4)/N*(5)/S(7)/T(2)

NDT

C/D/F/G/H/I/N/L/R/S/V/Y (61%)

W32

High

A(2)/D(1)/F(1)/G(1)/M(1)/N(2)/S(1)/W*(2)/Y*(6)/- (1)

NDT

C/D/F/G/H/I/N/L/R/S/V/Y (56%)

Y49

High

Y*(18)

TMT

S/Y (100%)

K50

High

A(2)/D(1)/G(5)/K*(3)/L(2)/S(2)/Y*(3)

HRC

C/H/N/R/S/Y (28%)

S52

Low

S(17)/T(1)

TMT

S/Y (94%)

S53

Mid

F*(2)/N(3)/R*(3)/S(6)/T(3)/Y(1)

HRC

C/H/N/R/S/Y (73%)

A55

Low

A(9)/F(1)/H(3)/K(1)/P(1)/Q(1)/Y(2)

Not varied

A (50%)

Y91

High

F(1)/G(3)/H(2)/R*(1)/S(3)/W*(2)/Y*(6)

HRC

C/H/N/R/S/Y (67%)

S92

High

A(1)/D*(1)/G(4)/L(1)/N*(3)/S*(4)/T(1)/W(1)/Y(2)

KMT

A/D/S/Y (44%)

N93

High

A(1)/D(1)/G(4)/H(1)/N*(5)/Q(1)/S*(1)/T(4)

RVC

A/D/G/N/S/T (89%)

Y94

Mid

L(3)/N(2)/S*(5)/T(3)/V(1)/W(2)/Y*(1)/- (1)

DMT

A/D/N/S/T/Y (61%)

P95

Mid

L(2)/P*(16)

Not varied

P (89%)

L96

High

F*(2)/I(1)/L*(1)/P(5)/R(1)/S(1)/W(4)/Y(3)

YDT

C/F/H/L/R/Y (39%)

T97

Low

R(1)/T(17)

Not varied

T (94%)

D5 position
LCDR1

LCDR2

LCDR3

A ‘contact score’ for each position was assigned based on inspection of the antibody-antigen crystal structures in Additional file 1: Table S1. The involvement of
each residue side chain was scored based on the buried surface area upon complex formation; positions that constituted a major element of the structural
paratope in multiple antibodies were ranked ‘high’.
B
The amino acid identities and their observed frequency are listed. Residues that were heavily involved in the interaction in at least one antibody-antigen
complex are indicated with an asterix. In some cases, loops lengths were shorter than D5; these are indicated by a ‘-‘at some positions.
C
Nucleotide degeneracies: D = A/G/T, K = G/T, H = A/C/T, M = A/C, N = A/G/C/T, R = A/G, V = A/G/C, Y = C/T.
D
‘Coverage’ indicates the percentage of the naturally observed diversity that is encoded in the degenerate codon.
A

encoded by the DVK codon, since HCDR3 has a high
degree of variability among all antibody scaffolds [27].
During synthesis of each library, we permitted ‘WT’
D5 side chain identity in both HCDR3 and LCDR1 by
using template DNA that contained WT D5 side chain
identity at these positions. Our rationale for this approach was to examine whether WT D5 sequences in
HCDR3 and LCDR1 would be preferred to library sequences; if so, then clones containing these WT sequences should be selected over clones that contain
library sequences. Both libraries were produced in bivalent scFv format with 3 x 109 unique members each.
Analysis of selectants

We screened both libraries for three rounds against 5Helix. A large number of clones from the round 3 (R3)
populations from both libraries were characterized by sequence analysis and monoclonal ELISA. Fifty-five of the
276 clones from D5-Lib-I R3 population contained library
sequences and had positive but moderate binding signals
for 5-Helix (OD450 > 0.4). Furthermore, these clones
displayed moderate specificity for binding to 5-Helix (~4-

fold ELISA signal for binding wells coated with 5-Helix in
comparison to wells coated with BSA). In contrast, selection of D5-Lib-II resulted in a R3 population that was dominated by library members (186 of 192) that had strong
positive ELISA signals for 5-Helix (OD450 > 1.0), and were
highly specific (10-fold or higher over BSA). The fact that a
high percentage of clones from the R3 population of D5Lib-II contain library sequences and that many of these had
strong, positive ELISA signals suggests that functional
clones can be readily isolated from this library. In contrast,
the lower amount of library sequences in R3 of D5-Lib-I
and the generally modest binding signals from isolated
clones indicate that functional clones are less readily
selectable.
The sequences of functional clones from the D5-Lib-II
selection were highly diverse (HCDR3 and LCDR1-3 sequences of 30 representative clones are shown in Table 3).
Interestingly, most of the hits identified contained WT D5
HCDR3 region but incorporated library sequences in all
three LCDRs. In contrast, the selectants from D5-Lib-I
were divergent in HCDR3 although one clone, 6G12,
contained the D5 HCDR3 segment (four representative
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Table 3 Sequences and phage ELISA profiles of selected clones
Amino acid sequenceA
Library

Clone

HCDR3

LCDR1

Phage ELISA signal ratioB
LCDR2

LCDR3

5-Helix/BSA (ratio) 5-Helix/LF (ratio) 5-Helix/KLH (ratio) FcompetitiveC

D5 WTD 95 DNPTLL 28 GIYHW 49 YKASSL 91 YSNYPL
D5-Lib-I

6G10

DAPPSP

SPDYY

DASYYH

DDHSPY

0.4/0.1 (5)

0.4/0.2 (3)

0.4/0.1 (3)

1.0

6G12

DNPTLL

GIYHW

SDYYSY

HAAYPH

0.6/0.1 (6)

0.6/0.3 (2)

0.6/0.2 (3)

0.8

6D9

DYPHHY

GIYHW

YHDYYP

SYPDPH

0.4/0.1 (5)

0.4/0.2 (3)

0.4/0.1 (3)

0.7

6B11

SHPDDD

DDADD

PYYASD

YDDHPP

0.4/0.1 (5)

0.4/0.2 (2)

0.4/0.2 (2)

1.0

DNPTLL

NINRN

SRASRL

RYNYPY

2.9/0.1 (22)

2.9/0.1 (21)

2.9/0.2 (12)

0.2

DNPTLL

NIYGN

SRASRL

RYTYPL

3.2/0.1 (34)

3.2/0.1 (33)

3.2/0.2 (18)

0.1

D5-Lib-II 25B8
25C10

A

25D8

DNPTLL

GISSN

SRAYRL

RATYPL

3.2/0.1 (30)

3.2/0.1 (22)

3.2/0.2 (18)

0.2

25A10

DNPTLL

SISHN

SNASRL

YSNYPL

3.2/0.1 (23)

3.2/0.1 (22)

3.2/0.2 (14)

0.1

25D9

DNPTLL

DILGR

YRASRL

RANYPL

3.0/0.1 (23)

3.0/0.1 (24)

3.0/0.2 (17)

0.2

25G8

DNPTLL

SIGRS

YRASRL

SSTTPL

2.1/0.1 (24)

2.1/0.1 (25)

2.1/0.1 (16)

0.1

25C6

DNPTLL

NISSR

SNAYHL

RSNYPH

1.8/0.1 (25)

1.8/0.1 (20)

1.8/0.1 (15)

0.2

25C12

DNPTLL

DISSV

YNASRL

RANNPH

2.2/0.1 (23)

2.2/0.1 (18)

2.2/0.2 (10)

0.3

25D6

DNPTLL

NIYSN

SSASRL

NSNNPH

1.6/0.1 (21)

1.6/0.1 (19)

1.6/0.1 (14)

0.1

25D3

DNPTLL

NIHRR

YSAYSL

NSDYPH

1.6/0.1 (20)

1.6/0.1 (17)

1.6/0.2 (10)

0.1

25F1

DNPTLL

GINNS

SRASRL

YSSTPH

2.3/0.1 (24)

2.3/0.1 (20)

2.3/0.1 (15)

0.1

25B6

DNPTLL

NIRSG

YRASRL

YDDYPH

1.4/0.1 (16)

1.4/0.1 (15)

1.4/0.1 (11)

0.1

25F10

DNPTLL

GIHNR

SHASNL

YSNYPL

1.7/0.1 (22)

1.7/0.1 (22)

1.7/0.1 (13)

0.1

25A12

DNPTLL

GIHRY

YHASRL

RANYPY

3.2/0.1 (27)

3.2/0.2 (20)

3.2/0.3 (12)

0.1

25A5

DNPTLL

SIRSH

SRASRL

SSDYPH

3.5/0.1 (24)

3.5/0.1 (24)

3.5/0.2 (15)

0.1

16F6

DNPTLL

SISSI

SNASRL

RSNYPF

3.0/0.2 (13)

3.0/0.3 (11)

3.0/0.7 (4)

0.8

25C5

DNPTLL

DIHDY

SRASRL

NDSYPY

0.7/0.1 (10)

0.7/0.1 (8)

0.7/0.1 (6)

0.5

16D10

DNPTLL

NIRGS

YRASRL

HSDYPH

3.0/0.1 (20)

3.0/0.2 (20)

3.0/0.5 (7)

0.7

16G6

DNPTLL

GIRRS

SNASHL

YYNYPR

2.3/0.2 (14)

2.3/0.2 (12)

2.3/0.3 (7)

0.3

16B7

DNPTLL

NILRL

YYASSL

RADYPY

3.0/0.1 (33)

3.0/0.1 (22)

3.0/0.5 (6)

0.6

16E12

DNPTLL

GIRRS

SNASHL

YYNYPR

3.1/0.4 (9)

3.1/0.3 (12)

3.1/0.7 (5)

0.1

25F12

DNPTLL

GIIGH

YNASRL

RDDYPL

2.7/0.1 (27)

2.7/0.1 (23)

2.7/0.2 (12)

0.2

25B4

DNPTLL

GIRNG

SRASHL

YYAYPH

2.9/0.1 (29)

2.9/0.1 (31)

2.9/0.1 (22)

0.1

16E8

DNPTLL

SIYGS

SHASHL

NDTYPH

3.0/0.1 (21)

3.0/0.2 (12)

3.0/0.3 (9)

0.4

25E1

DNPTLL

DIGGS

SHAYSL

HATYPH

3.0/0.1 (32)

3.0/0.1 (28)

3.0/0.2 (20)

0.1

25A6

DNPTLL

GIYDG

SRAYYL

RANYPH

3.1/0.2 (20)

3.1/0.1 (25)

3.1/0.2 (16)

0.1

16E3

DNPTLL

GIRYG

SRASRL

HYAYPH

3.0/0.3 (11)

3.0/0.4 (8)

3.0/0.6 (5)

0.7

2H10

DNPTLL

DIYRS

SRASRL

YSNYPL

1.9/0.1 (15)

1.9/0.1 (19)

1.9/0.2 (10)

0.1

25C4

DNPTLL

SILGS

YRASHL

YSNYPL

2.5/0.1 (32)

2.5/0.1 (26)

2.5/0.1 (19)

0.1

16F5

DNPTLL

NINDH

SRAYRL

YADTPF

3.0/0.2 (19)

3.0/0.2 (12)

3.0/0.3 (11)

0.2

In cases where selection of the entire CDR was observed (for HCDR3 and LCDR3), the sequence is italicized. Positions that were not randomized are underlined.
For each clone, the raw ELISA signal (OD450) is shown against both 5-Helix and control proteins BSA, lactoferrin (LF), or keyhole limpet hemocyanin (KLH). The
ratio of ELISA signals for 5-Helix over each of the three control proteins is shown in parentheses.
C
The reduction in ELISA signal observed upon preincubation with free 5-Helix (500 nM, D5-Lib-I; 40 nM, D5-Lib-II) as a fraction of the signal observed in the
absence of the competitor.
D
Kabat numbering for the first residue of each CDR is shown for D5 WT.
B
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clones are shown in Table 3). This observation suggests
that solutions to high affinity 5-Helix recognition are restrictive in HCDR3 but permissive in the LCDRs. Furthermore, the high hit-rate obtained with D5-Lib-II is striking
in light of the fact that it contains a 100-fold higher degree
of theoretical diversity than does D5-Lib-I but was produced with an equivalent number of library members.
This result suggests that the functional capacity for recognition in VH1-69 antibodies is enhanced with pairing of
VK domains containing appropriate amino acid substitutions. These findings are in agreement with our previous
work demonstrating that extended interactions among the
heavy and light chains are required for 5-Helix recognition
by D5 [5].
We used high-throughput ELISAs to assess specificity
and affinity among the selectants. To examine specificity,
we performed the phage ELISA against 5-Helix and two
control proteins in addition to BSA: lactoferrin (LF) and
keyhole limpet hemocyanin (KLH). LF is a ubiquitous protein found in many tissues, but was not introduced in the
selection (BSA was used as a blocking reagent) and therefore provided a good control for testing specificity against
unrelated proteins. KLH is known to be strongly immunogenic and is frequently employed as a carrier protein for
immunogenicity and vaccination studies [28]. We surmised that polyspecific clones (i.e., those displaying properties of unevolved antibodies) would have reactivity with
this protein; therefore cross-reactivity with KLH served as
another stringent measure of specificity. By determining
the ratio of ELISA reactivity for 5-Helix over BSA, LF, or
KLH we could rapidly assess the specificity of each
selectant in a high-throughput manner.
In addition, we performed a single-point competitive
phage ELISA experiment in which each phage clone was
preincubated with soluble 5-Helix prior to capture in an
ELISA well containing immobilized 5-Helix. Those
clones with higher affinity should therefore have a higher
occupancy of 5-Helix in the combining site from the
preincubation, hence a lower ELISA signal. Similar strategies have been used to assess other synthetic antibody
libraries. In general, phage clones in which the ELISA
signal is reduced by > 50% upon preincubation of 10 nM
or 100 nM free antigen results in antibodies with low or
mid nanomolar dissociation constants (respectively)
when the corresponding protein Fabs were purified and
assayed by SPR [17,27]. We found that preincubation of
D5-Lib-II selectants with 40 nM free 5-Helix provided a
large dynamic range of ELISA signals among selectants,
therefore we used this concentration to assess relative
affinities for these clones. Selectants from D5-Lib-I were
generally lower affinity and consequently necessitated a
higher concentration of free 5-Helix (500 nM) for the
competition assay. The data are represented as the fraction of ELISA signal observed in the presence of the free
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5-Helix relative to the signal observed without competitor (Fcompetitive, Table 3).
Table 3 lists representative clones from D5-Lib-I and
D5-Lib-II selection along with results from specificity profile analysis and single-point competition ELISA. This analysis revealed that selectants from D5-Lib-II contained
varying levels of specificity for 5-Helix over BSA, LF, and
KLH although generally the selectivity for 5-Helix was
strong. The ratio of ELISA signals for 5-Helix over each of
the control protein was at least 5-fold in all cases and, for
most clones, an over 10-fold ratio was observed against all
three control proteins. Furthermore, the affinity, as
assessed by Fcompetitive, was high in most cases since the 40
nM free 5-Helix resulted in more than 50% reduction in
ELISA signal (Fcompetitive < 0.5) for nearly all of the clones.
Notably, three of the clones with the best selectivity and
affinity profiles (25A10, 2H10, and 25C4) contained
LCDR3 sequences that are identical to WT D5. However,
similarity to the D5 LCDR3 region was not an absolute
necessity; clone 25D6 exhibited high affinity and specificity
but contained no homology to D5 in the LCDR3 region.
Selectants from D5-Lib-I were generally less specific and
had poor affinity. The ratio of ELISA signals for 5-Helix
over BSA did not exceed 6-fold. Furthermore, only moderate competition was observed upon addition of 500 nM
free 5-Helix in two cases (6G12 and 6D9). In the other
two cases, no competition was observed. The results
obtained with D5-Lib-I and D5-Lib-II suggest that restricted diversity in the context of this interaction is insufficient to provide highly functional clones, despite the fact
that sequence space in D5-Lib-I is much more adequately
sampled than in D5-Lib-II.
Conformational specificity

Antibody D5 inhibits HIV-1 infection by binding the
N- and C-heptad repeat regions of gp41 (NHR and CHR,
respectively) and sequestering a conformation known
as the ‘extended intermediate’ in the gp41-mediate viral
membrane fusion pathway that is required for virus entry
[6,29,30]. The target for D5, 5-Helix, is an engineered
protein containing the NHR and CHR segments designed
to mimic the ‘extended intermediate’ [29,31,32]. The critical
HCDR2 loop of D5 projects into a hydrophobic cleft that
should only be present in this conformational form of gp41
[6]. Therefore, antibody D5 is predicted to exhibit conformational specificity for the gp41 NHR and CHR – the
antibody should bind mimics of the extended intermediate
but not the ‘post-fusion’ form of this proteins (a six-helix
bundle) [31,32].
We sought to define the conformational preferences of
D5 and the selectants from D5-Lib-II. We prepared a
designed protein containing the gp41 NHR and CHR
segments which mimics the six-helix bundle ‘postfusion’ conformation (‘6-Helix-Fd’) [31,32]. This protein
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antibody clones, we performed competitive ELISA assays
in which binding to immobilized 5-Helix was inhibited
by binding free 5-Helix or free 6-Helix-Fd (sample data
for D5 are shown in Figure 2b). The IC50 obtained by
competition with free 5-Helix provides an estimate for
binding activity. Furthermore, the relative IC50 obtained
by competition with 6-Helix-Fd enables evaluation of

consists of the NHR linked to the CHR by a short linker,
followed by a trimeric coiled-coil segment from T4
fibritin (Foldon, Fd) to promote trimerization (Figure 2a)
[33]. 6-Helix-Fd was purified from E. coli by standard
procedures and found to be α-helical by circular dichroism consistent with design (see Additional file 1:
Table S1). To explore conformational specificity of the

(a)
6-Helix-Fd (post-fusion)

5-Helix (extended intermediate)
NHR1 CHR1 NHR2 CHR2 NHR3

CHR

NHR

D5 binding
face

Fd

6-Helix
Bundle

Fd

(b)
5-Helix
6-Helix-Fd

Fraction bound

1.0

0.5

0.0
0

-2

2

log [Concentration (nM)]

(c)

Fraction bound

1.0

0.5

0.0

-1

0

1

2

3

log [Concentration (nM)]

Figure 2 5-Helix and 6-Helix-Fd design and competitive ELISA. Design of 5-Helix and 6-Helix-Fd (a), and competitive ELISA with D5 scFv (b,
phage-bound bivalent scFv; c, purified monovalent scFv).
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preference for the extended intermediate conformation
over the post-fusion conformation. These results are summarized in Table 4 (full plots can be found in the Additional file 1: Table S1).
We previously reported an IC50 of D5 for 5-Helix
of 0.1 nM, and here we determined an IC50 for 6Helix-Fd of 11 nM (concentrations calculated for the
trimer; Figure 2b) [19]. Therefore, the D5 is able
to discriminate the extended and post-fusion conformations of gp41 by 100-fold difference in apparent affinity. Selectants from D5-Lib-II ranged in their
apparent affinity for 5-Helix, some were similar to D5
(e.g., 25D6, 25B6, and 25F10) but others had 10- or
100-fold higher IC50 (e.g., 25C10 and 25G8, respectively). However, most retained their ability to distinguish 6-Helix-Fd from 5-Helix by ~100-fold difference
in apparent affinity. In one case, 25D8, specificity for
5-Helix over 6-Helix-Fd was enhanced relative to D5
(~500-fold selectivity). We have previously shown that
analysis of binding to 5-Helix in this format, with the
antibody fragment displayed on phage, agrees well
with results using the purified antibody fragment [19].
To further validate this assumption, we purified
the scFv for D5 and several of the clones for binding
analysis. In general, the IC50 obtained for the purified
scFv proteins were ~10-fold higher than those
observed on-phage. However, the overall trends were
consistent with results on-phage for the clones
examined.

Positional preferences

Diverse populations of phage selectants can be used to
assess positional requirements for protein-protein interactions by determining the degree of conservation for a
particular residue in a functional selection (here, 5-Helix
binding) relative to a selection for protein display
[5,34-36]. In some cases, these datasets have been used to
infer energetic consequences of mutation provided certain
assumptions are validated [5,34-36]. We performed a selection of D5-Lib-II against the anti-FLAG antibody M2
to obtain a reference dataset to quantify display biases. A
FLAG epitope sequence was included at the N-terminus
of our scFv construct; therefore selection against M2
should provide readout of display bias. We compiled sequences for 179 clones from the 5-Helix selection that
scored well in terms of specificity profile analysis (OD450
ratios of four-fold or higher for 5-Helix over each of the
controls). For the reference (display) set, we compiled 168
sequences that had a strong, positive ELISA signal for M2
binding. At each position, we determined the percentage
occurrence of each residue and ranked from 1st to 4th
most frequent from the functional selection. At positions
49 and 52 of LCDR2, the randomization encoded variation
between just two amino acids (Tyr and Ser). These data
are represented in Table 5, with the identity of the WT D5
residue preceding the residue number in the first column
and the four most frequent residues from the functional
selection listed in order of frequency. In cases where additional residues were permitted and observed, these were

Table 4 Apparent affinities of clones from D5-Lib-II selection against 5-Helix
On-phage (bivalent)

Off-phage (monovalent)

Clone

IC50 for 5-HelixA/nM

IC50 for 6-Helix-FdA/nM

IC50 for 5-HelixA/nM

IC50 for 6-Helix-FdA/nM

D5 WT

0.1 (0.07-0.1)

11 (8–15)

7.3 (5.3-10)

290

B

NDB

25B8

3.1 (1.8-5.3)

~100

ND

25C10

1.8 (1.3-2.7)

28 (21–37)

56 (40–79)

NCC

25D8

5.8 (4.2-7.5)

~3000

NDB

NDB

25A10

1.6 (1.3-2.0)

260 (150–450)

5.4 (3.8-7.7)

~500

25D9

1.7 (1.4-2.1)

230 (150–360)

ND

B

NDB

B

NDB

25G8

7.2 (4.2-12.3)

300 (120–750)

ND

25C6

32 (24–44)

~1000

NDB

NDB

B

NDB

25C12

100 (31–300)

~1000

ND

25D6

0.5 (0.3-0.8)

~80

NDB

NDB

B

NDB

25D3

17 (9.9-30)

170 (70–390)

ND

25F1

0.9 (0.7-1.2)

40 (20–79)

NDB

NDB

25B6

0.3 (0.2-0.4)

23 (15–36)

0.6 (0.3-1.0)

94 (56–160)

B

25F10

0.2 (0.2-0.3)

22 (16–30)

ND

25A12

2.2 (1.2-4.0)

220 (70–670)

34 (23–52)

A

95% Confidence intervals from data fitting are shown in parentheses.
B
ND, not determined.
C
NC, no convergence observed upon data fitting, suggesting weak or insignificant binding.

NDB
280 (120–640)

1stA

2ndA

3rdA

Function
Display %
Function/
% (5-Helix) (Anti-FLAG) DisplayC
GB

4thA

Function
Display %
Function/
% (5-Helix) (Anti-FLAG) DisplayC

OthersA

Function
Display %
Function/
% (5-Helix) (Anti-FLAG) DisplayC

Function
Display %
Function/ Function
Display %
Function/
% (5-Helix) (Anti-FLAG) DisplayC % (5-Helix) (Anti-FLAG) DisplayC

38

34

1.1

N 25

21

1.2

D

19

20

1.0

S

19

25

0.8

0

0

-

Y30* H

22

9

2.4

S

13

4

3.2

R

13

11

1.2

G

11

9

1.2

41

67

0.6

H31

R

23

5

4.6

S

19

4

4.8

G

15

5

3.0

N

14

16

0.9

29

70

0.4

W32 S

26

14

1.9

N 19

7

2.7

R

16

8

2.0

H

14

11

1.3

25

60

0.4

Y49

S

60

45

1.3

Y 40

55

0.7

-

-

-

-

-

-

-

-

-

K50* R

61

10

6.1

N 15

18

0.8

13

23

0.6

7

17

0.4

4

32

0.1

-

-

-

-

-

-

-

-

-

G28

H

S

S52

SB

77

49

1.6

Y 23

51

0.4

S53

R

54

19

2.8

H 22

17

1.3

SB 11

22

0.5

N

16

0.5

5

26

0.2

Y91

R

36

13

2.8

N 20

17

1.2

S

18

15

1.2

YB 14

24

0.6

12

31

0.4

S92

SB

34

30

1.1

A 27

20

1.4

Y

27

30

0.9

D

12

20

0.6

0

0

-

N93

NB

31

28

1.1

D 18

10

1.8

A

17

13

1.3

T

17

28

0.6

17

21

0.8

Y94* YB

71

20

3.6

T

13

21

0.6

S

6

17

0.4

N

5

L96

35

14

2.5

F

19

15

1.3

Y

19

19

1.0

LB 15

H

8

11

0.4

5

31

0.2

25

0.6

12

27

0.4
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Table 5 Apparent affinities of clones from D5-Lib-II Selection against 5-Helix

A

For each position, the percentage of the population of analyzed clones is shown for the 1st, 2nd, 3rd, and 4th most frequently observed residue from the 5-Helix selection. The WT D5 residue is indicated prior to the
position number in the first column and the “hotspot” positions identified by Da Silva et al. are marked by asterisk. If two of the amino acids exhibit the same frequency, the one with the higher Function/Display
ratioC will rank in a higher order. In cases where additional substitutions were permitted and observed, these were binned into a 5th category labeled ‘other’. At positions 49 and 52, only two residues (Tyr and Ser)
were permitted. The data shown here were compiled from 178 sequences from the 5-Helix selection and 169 sequences from the display selection.
B
Amino acids shown in the four most frequently observed at each position among library members that are identical to WT D5 are shown in gray italic font. For positions that the WT residue was not encoded in the
library due to codon degeneracy, amino acids that have the closest physiochemical properties to the WT that is among the four most frequent residues are in black italic fonts.
C
Ratio of percent frequency observed from functional (5-Helix) selection and percent frequency observed from display (anti-FLAG) selection.
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binned together into a fifth class, ‘other’. For each residue,
we calculated the ratio between occurrence in the functional and display selections (F/D); this analysis provide a
direct evaluation of the extent to which a particular side
chain is enriched in the functional (5-Helix) selection
population over the display (anti-FLAG) selection. Stronger preferences for function are indicated by both high occurrence (% of population in the functional selection) and
F/D > 1. While this analysis provides a rough guideline for
identifying biases for recognition, caution must be used in
analysis of these data since there is no error estimate associated with occurrence or F/D.
Nearly every position in the LCDRs exhibits specific
preferences in the population for functional selection, as
indicated by F/D > 1 for the 1st and 2nd most frequently
observed residue. Four positions correspond to residues
in D5 that had high energetic cost for mutation to alanine (ΔΔGAla-WT ≥ 1.0 kcal/mol, ‘hot spot’ residues) in
our previous scanning mutagenesis experiments: Y30,
K50, Y94, and L96 (marked with an asterix in Table 5).
All of these positions had a preference for the most
commonly-observed residue from the D5-Lib-II selection (F/D >1). Polar and charged residues were preferred
at LCDR positions 30 and 32, despite the fact that these
positions are occupied by large hydrophobes in D5 (Tyr
and Trp, respectively). We previously demonstrated that
Y30 has ΔΔGAla-WT of 1.0 kcal/mol [5]. Therefore, variations in other portions of the LCDRs must allow for less
hydrophobic residues at position 30. In positions 31
(LCDR1), 49 and 53 (LCDR2), the preferred residues
(Arg, Ser, Arg, respectively) were not the D5 WT residue
(His, Tyr, Ser, respectively), despite the fact that the WT
residue was included in the randomization set. In contrast, in positions 92, 93, and 94 of LCDR3, the WT D5
side chain identity was preferred. This result suggests
that LCDR3 diversity is more restrictive. Tyr was highly favored in position 94 (F/D = 3.6); this position lies at the
center of the interface and corresponds to a strong hot spot
residue in D5 (Y30 has ΔΔGAla-WT of 2.6 kcal/mol). Position 50 in LCDR2, which corresponds to another strong
hot spot residue in D5 (K50, ΔΔGAla-WT = 2.1 kcal/mol)
[5], had a strong preference for cationic side chains. Arg
and His accounted for > 70% of the population; and Arg
had a F/D of 6.1. In position 96, His was preferred but this
position is occupied by Leu in D5 and is another hot spot
residue (ΔΔGAla-WT = 1.5 kcal/mol).
Overall, the population analysis of functionallyselected R3 clones suggest that there is some degree of
flexibility and permissiveness for 5-Helix recognition by
D5, but that LCDR3 positions 92, 93, and 94 favor the
WT D5 residues. It is somewhat surprising that hydrophobic residues, particularly Tyr, were not more strongly
favored at the LCDR positions in the functional selection. Tyr is the most commonly observed residue in
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functional and naïve CDR positions and plays critical
roles in recognition by natural and synthetic antibodies
[4,16]. In four of the 13 positions examined, Tyr is found
at the corresponding site in D5 (Y30, Y49, Y91, and
Y94); furthermore, Tyr was permitted at these positions
and seven others in D5-Lib-II but was only strongly favored at position 94. In contrast, cationic or polar residues were abundant in most positions. These results
suggest that LCDR contacts in this context provide polar
or ionic contributions to binding, either directly or indirectly. Position 94, which showed the highest degree of
preference for Tyr, was also the residue found to have
the highest ΔΔGAla-WT in our previous alanine scanning
studies. Examination of the clones in Table 3, however,
demonstrates that Tyr at this position is not an absolute
requirement – clones 25D6 and 25F1 rival D5 in terms
of specificity and affinity yet contain polar residues at
position 94 (Asn and Thr, respectively). However, both
of these clones contained Tyr at other LCDR positions.
Another interesting observation is that restrictiveness in
positional side chain identity for D5-Lib-II selectants
against 5-Helix did not correlate with ΔΔGAla-WT values
previously observed in D5. For example, Y30 and L96 of
D5 were found to have ΔΔGAla-WT ≥ 1.0 kcal/mol in the
alanine scanning studies but these positions had only
moderate functional preferences, and these preferences
were not for the WT D5 side chain identities even though
Tyr and Leu were encoded in the randomization set at positions 30 and 96. These results match comprehensive
scanning studies on the human growth hormone-receptor
interaction in which ‘hot spot’ residues (i.e., those with
ΔΔGAla-WT ≥ 1.0 kcal/mol) correlated with some, but not
all, positions that had stringent requirements for side
chain identity [37]. Furthermore, the preferred amino
acids in the LCDR positions did not correlate with those
most frequently observed in the analysis of the 18 VH169-related antibodies; and those positions that had the
most stringent amino acid preferences were not necessarily those assigned a high contact score in the structural
analysis. Therefore, the functional preferences for LCDR
side chain identity are likely context-dependent.
Among the analyzed clones, the combining site of 25B6
maximizes both hydrophobic and electrostatic features
given in the D5-Lib-II diversity (Table 3). By our metrics,
25B6 scFv has a higher relative affinity compared to D5
(IC50 of 0.6 nM for 25B6 and 7.3 nM for D5). This clone
contains positive charges in positions 30, 50, and 53 (Arg),
and negative charges at positions 92 and 93 (Asp). Overall,
Asp was not a frequent substitute in this selection;
however, Asp at positions 92 and 93 may enhance interaction with the positively charge residues in the
N-terminal heptad repeat (NHR) [5]. To better understand
the nature of potential charged residue interactions at
those positions, we used the FixedBBProteinDesign
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Figure 3 Optimized complementarity in the 25B6-5Helix interaction revealed by modeling. (a) Structural model of 25B6 complexed with
5-Helix (in cartoon) is superimposed onto the crystal structure of D5-5-Helix complex (PDB ID 2CMR). 25B6 is colored in deep olive, D5 in cyan,
and 5-Helix in orange. Side chains of residues participating in the interaction are shown as stick; for 5-Helix, the side chains are colored teal in the
D5-5-Helix model, and orange in the 25B6-5-Helix model. Electrostatic potential surface of 5-Helix from the 25B6 modeling is shown as well. (b)
Potential of R30 in 25B6 to contact several residues on the periphery of the 5-Helix. (c) Potential interaction of E157 (5-Helix) with R50 and R53 of
25B6. (d) Potential polar interactions between 25B6 and 5-Helix mediated through D92 and D93 and a water molecule.

module in Rosetta3 to obtain a model of the 25B6 interaction with 5-Helix [38,39]. The crystal structure of the
D5-5-Helix (PDB ID 2CMR) and structural model of 25B6
are superimposed in Figure 3. All three Arg residues in
25B6 have the potential to engage in favorable electrostatic
interactions with 5-Helix. In position 30, the long carbon
chain of Arg in 25B6 acts as the edge of an overall concave
surface into which the α-helices of 5-Helix are nestled.
This predicted interaction is similar to that of Y30 in D5
[5,6]. Similarly, the extended length of Arg in position 50
and 53 results in the potential for formation of electrostatic interactions with E156 of the CHR of the 5-Helix.
The long carbon chain of R50 can potentially make van
der Waals contact with H153. On the other hand, the two
Asp residues that occupy position 92 and 93 can form salt
bridges with, or provide electrostatic complementarity to
K574 of 5-Helix. Such interactions may contribute to the
high affinity interaction between 25B6 and 5-Helix.

Discussion
Our high throughput analysis of selectants from D5-Lib
-II indicates that the pool contained diverse clones with
a variety of binding affinities. Interestingly, most clones
maintained their specificity at both the antigen level (as

judged by the high throughput ELISA ‘specificity analysis’) and many retained conformational specificity (as
judged by recognition for 5-Helix over 6-Helix-Fd). Global sequence analysis of functional clones suggested
LCDR1 and LCDR2 could accommodate many residues
while LCDR3 was more restrictive. This may reflect
biases of natural antibodies to utilize LCDR3 as a predominant contact region. Furthermore, we previously
reported that the D5 LCDR3 contains several hot spot
residues [5]. Therefore, it seems this region is important
for recognition of 5-Helix in multiple contexts. On a
clonal level, it appears there are many recognition solutions while retaining D5-like affinity and specificity. As
an example, clones 25D6, 25F1, 25B6, and 25F10 were
comparable to D5 by our metrics but had very different
LCDR features. In particular, 25B6 contains Arg in position 30, 50, and 53, and Asp in position 92 and 93. It is
conceivable for the charged residues in the light chain enhance stability and solubility on a very hydrophobic VH
antigen-binding surface; it is also reasonable to speculate
that the charge residues can be used to improve overall
binding interface by electrostatic complementarity.
The observation that D5-Lib-I did not yield D5-like
clones is surprising in light of the fact that the critical
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HCDR2 loop of the VH1-69 germline segment is included in these two repertoires. Interactions of two
hydrophobic residues (I53 and F54) in the HCDR2 of
CR6261 were enough to trigger B cell activation [14].
And importantly, a handful of somatic hypermutations
were enough to allow D5 to bind 5-Helix in low
nanomolar to high picomolar affinity. Thus, inclusion of
residues that have important physiochemical properties
biased toward protein-protein interaction should be sufficient to yield functional clones. However, our results
indicated that interactions with 5-Helix using a VH1-69
germline clearly require extended interactions of a very
specific nature involving the light chain [5]. Libraries
based on the VH1-69 scaffold may therefore require a
much larger diversity to achieve high affinity and specificity. We conclude that while there are some requirements
in side chains of the LCDR positions (as demonstrated by
the moderate functionality of clones from D5-Lib-I), there
is some permissiveness for affinity and specificity of the
5-Helix antibody recognition provided the correct attributes are present.
Humoral immunity requires a delicate balance of a
broadly reactive naïve repertoire (i.e., ‘germline-encoded’
antibodies) and highly specific evolved antibodies. Structural and biochemical work on hapten-binding antibodies
has demonstrated that germline-encoded antibodies typically exhibit polyreactivity through dynamic CDRs [39-41].
Mutations that arise during affinity maturation reduce the
flexibility of the CDR segments such that they are locked
into a conformation that is productive for antigen binding.
This “conformation locking” mechanism may have played
a role in dominance of WT HCDR3 because of the degeneracy of the codon set did not allow Pro to be permitted
in position 97 in D5-Lib-II, a residue that is important for
the interaction with D5.
However, it is less obvious how protein-binding antibodies evolve specificity and affinity. Studies with an
anti-hen egg white lysozyme (HEL) antibody and its
germline-encoded progenitors suggests that affinity maturation in this case involves optimization of CDR loop
conformations by mutation of a residue at the VH-VL
interface [42]. Similar to other protein-protein interactions, the affinity of protein-antibody interactions is significantly influenced by the complementarity of the two
interacting surfaces and the exclusion of water at the
intermolecular interface [43]. In the case of the anti-HEL
antibodies, a key mutation at the VH-VL interface resulted
in HCDR1 and HCDR2 displacements that optimized the
overall antigen-binding surface. This model is unlikely to
be generalizable since the vast majority of matured
protein-antibody interactions involve a high degree of mutation in the CDR segments. Furthermore, in vitro evolution of protein-binding antibodies can be achieved by
mutagenesis of the CDR segments alone [44].
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We previously examined the D5-5-Helix interaction by
scanning mutagenesis and found that the high affinity results from extended interactions involving the VH and VL.
Here we find that both affinity and specificity can be altered with mutations in the LCDRs and HCDR3. The fact
that positions in the functional paratope of the D5-5-Helix
complex (as determined by a large ΔΔGAla-WT in alanine
scanning mutagenesis studies) were permissive while
retaining affinity and specificity suggests that there are
multiple solutions to evolution of binding. However, the
hexanomial restricted diversity library D5-Lib-I did not
yield high affinity clones; this result suggests that some
functional constraints do exist, and that these constraints
differ from other germline scaffolds.

Conclusions
Here we have explored side chain requirements for
binding and specificity in D5, a model HIV-1 antibody
derived from the VH1-69 germline segment. These results provide a template for future synthetic antibody libraries based on this germline scaffold, and provide
novel insights into protein-antibody recognition.
Methods
Expression and purification of 5-Helix and 6-Helix-Fd

5-Helix was isolated essentially as described [5,29]. A
synthetic gene encoding the 6-Helix-Fd sequence (see
Additional file 1: Table S1 for details) was obtained from
a commercial supplier (Genewiz, South Plainfield, NJ)
and cloned into pET22b using NdeI and XhoI restriction
sites to produce the expression plasmid pLR22. E. coli
BL21(DE3) cells (Invitrogen, Madison, WI) harboring
pLR22 were grown in LB broth at 37°C to OD600 ~0.6,
and expression induced by the addition of 0.5 mM
isopropyl-β-D-thiogalactopyranose (IPTG). The culture
was incubated overnight at 15°C. The cells were isolated
by centrifugation and lysed in a French pressure cell. The
soluble and insoluble fractions were separated by ultracentrifugation; the 6-Helix-Fd protein was contained in the
insoluble fraction. The insoluble fraction was resuspended
in 6 M GdnHCl, the cell debris removed by centrifugation,
and the supernatant applied directly to Ni-NTA resin
(Qiagen, Valencia, CA). The resin was washed with 20 mL
of 6 M GdnHCl/20 mM imidazole, then with 20 mL of 6
M GdnHCl/50 mM imidazole and the protein was eluted
with several fractions 6 M GdnHCl/200-500 nM imidazole. The fractions containing the purified protein were
pooled, and refolded by dialysis into phosphate-buffered
saline (PBS, pH 7). The protein was either used immediately for analysis or flash frozen and stored at – 80°C.
Phage display

The D5 scFv display phagemid pJH3 [5] was altered to
allow bivalent D5 scFv display to produce phagemid
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pJH3B. The open reading frame (ORF) consisting of the
D5 scFv sequence upstream of the C-terminal 188 residues of M13 phage coat protein pIII (pIII-CT) in pJH3
was expanded to include an IgG hinge region and a
GCN4 leucine zipper segment between the scFv and
pIII-CT. The final construct (pJH3B) has an ORF
containing the OmpA periplasmic export sequence, an
N-terminal FLAG epitope (for detection), the D5 scFv,
the IgG hinge region, GCN4, and pIII-CT as a single
chimeric fusion protein. Phage ELISA and Western blotting confirmed functional display of the bivalent D5 scFv
assembly on phage particles (not shown). Bivalent display of the CR6261 scFv was similar; a synthetic DNA
fragment encoding the CR6261 scFv codon optimized
for E. coli was obtained from DNA 2.0 (Menlo Park,
CA) for construction of this display vector. For crossreactivity studies, influenza HA was purchased from
Sino Biological Inc. (Beijing, P.R. China).
Phage growth and ELISA analysis was performed using
standard methods [5,45]. E. coli XL1-Blue harboring the
appropriate phagemid were grown to mid-log phase in LB
broth supplemented with 5 μg/mL tetracycline and 50 μg/
mL carbenicillin. Helper phage VCSM13 (Stratagene,
Santa Clara, CA) or M13K07 (New England Biolabs,
Ipswitch, MA) were added to 1010 plaque-forming units
(pfu)/mL followed by 25 μg/mL kanamycin. The culture
was grown 18 hrs at 30°C, the cells removed by centrifugation, and phage precipitated by addition of 3% (w/v)
NaCl and 4% (w/v) PEG 8000. The phage were pelleted
by centrifugation and resuspended in PBS containing 1%
BSA. For phage ELISA, wells of Costar EIA/RIA highbinding plates were coated with antigen (typically 0.2 –
1.0 μg/well) in 100 mM NaHCO3 pH 8.5 at room
temperature for 1 hr or at 4°C overnight. The well solutions were decanted and unbound sites were blocked by
incubation with PBS containing 1% BSA for 1 hr. The
wells were washed with PBS containing 0.05% Tween 20
(PBS-T), then the phage solutions were added and allowed
to bind at room temperature for 0.5 – 1 hr. The phage solutions were decanted, the wells washed 5 – 7 times with
PBS-T, then a solution containing anti-M13-horseradish
peroxidase conjugate (GE Healthcare, Piscataway, NJ) was
added and allowed to bind for 0.5 – 1 hr as directed by
the manufacturer. The wells were washed with PBS-T and
developed by addition of a 3, 3’, 5, 5’-Tetramethylbenzidine
(TMB) substrate. The ELISA signal was quantified either
by direct measurement of blue color absorbance (OD650)
or by quenching with H2SO4 after 10 mins and determining the OD at 450 nm.
Library construction

Library DNA was prepared using Kunkel mutagenesis
[5,19,45]. A template clone based on pJH3B (see above)
was prepared in which LCDR2 and LCDR3 regions were
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replaced with poly rare-Arg codon-containing segments.
We have found that rare-Arg codon-containing segments
provide enhanced selection relative to similar strategies
that use stop codon-containing template clones because
the residual rare Arg-codon template is less prone to
growth advantages. Single-stranded, uridine-enriched
DNA (ss-dU-DNA) of rare Arg-containing template clone
was prepared in CJ2036 E. coli (NEB) using established
protocols. Kunkel mutagenesis performed using 5’phosphorylated primers corresponding to the reverse
complement of the designed library sequences as previously described [5]. In general, Kunkel reactions contained
10 μg of template DNA, three-fold excess of library primer, three units of T7 polymerase and two units of T4 ligase. These reactions were incubated at room temperature
overnight and then the library DNA purified using a
QIAgen PCR purification kit.
The E. coli clone SS320 was used for library
electroporations and was prepared by mating MC1016 and
XL1-Blue [19,45]. The purified library DNA was
electroporated into SS320 competent cells that had been
preinfected with VCSM13 or K07. Typical electroporations
were performed with 350 μL of competent cells and 10 μg
of purified library DNA in 0.2 cm cuvettes using a BioRad
Gene Pulser electroporator (2.5 kV and 200 Ω). Cells were
allowed to recover for 45 min at 37°C and then large scale
phage production was performed as above. Library phage
were suspended in PBS and either used immediately for
screening or stored at – 80°C. The final library phage preparations had high infectious titer (1012 – 1013 pfu/mL).
The quality was assessed by large-scale DNA sequencing
of phage clones; in all cases, the libraries were highly diverse in sequence and contained ~ 30% functional library
members.
Library selection and analysis

Library sorting was performed in Costar EIA/RIA plates;
the antigen was immobilized into plate wells as above.
Library phage were added and allowed to bind for 1 – 2
hrs, then the wells were washed extensively with PBS-T.
The binding phage were eluted by treatment with 100
μL of 100 mM glycine HCl pH 2.0 for 10 min, and the
solution was neutralized by addition of 50 μL of 2 M
Tris, pH 8.0. The neutralized phage solution was then
added to 5 mL of log-phase XL1-Blue E. coli in 2×YT
broth supplemented with tetracycline. After 1 hr, 50 μg/
mL carbencillin along with helper phage were added and
the culture was grown at 37°C for 1 hr. Subsequently,
25 mL of 2×YT containing 50 μg/mL carbenicillin and
25 μg/mL kanamycin were added and the culture was
grown at 30°C for 18 hrs. The cells were removed by
centrifugation, then the phage was isolated as above and
used immediately for subsequent rounds of infection. Selection progress was monitored by 1) large-scale
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sequencing of the phage populations (to look for enrichment of library clones) and 2) output phage titers from
wells containing the target to wells containing a BSA
control.
Individual clones were grown small scale for highthroughput phage ELISA analysis in deep 96-well plates.
Cultures of 1 mL LB broth containing carbencillin were
inoculated with colonies corresponding to selectants,
helper phage were added (1010 pfu/mL) and the culture
grown at 30°C for 18 hrs. The cells were removed by
centrifugation and the supernatant applied directly to
ELISA plate wells in which the antigen or control protein had been immobilized. Phage solutions were
allowed to bind for 15 mins, the wells washed with
PBS-T, and then the bound phage detected with the
anti-M13/HRP conjugate as above. For specificity profile
analysis, LF and KLH were purchased from Sigma-Aldrich
(St. Louis, MO). Single-point competitive ELISAs were
similar except that the phage solutions were preincubated
with 40 nM 5-Helix for 30 min before addition to wells
containing the immobilized 5-Helix. Both specificity profile analysis and single point competition analysis were
spotchecked for reproducibility and, in general, gave
consistent results among independent experiments.
Competitive phage ELISAs were performed essentially as
described [19].
Expression of scFv proteins and monoclonal ELISAs

Phagemid vectors were converted to expression vectors
by replacement of the hinge, GCN4 and pIII-CT segment downstream of the scFv segment with a
hexahistidine tag. The scFv proteins were expressed in
the periplasm of E. coli BL21. Cultures were grown in
low-phosphate media at 30°C for 14 – 16 hrs and the
cells harvested by centrifugation. Cell lysis was achieved
by treatment with Bug Buster (Novagen, Madison, WI).
The lysate was clarified by ultracentrifugation and purified by nickel affinity chromatography. Purified scFv proteins were dialyzed into PBS then used immediately for
analysis or flash frozen and stored at – 80°C. Analysis
by ELISA was similar to phage ELISA except that an
anti-FLAG/HRP conjugate was used to detect the scFv
protein (a FLAG epitope is present at the N-terminus).
Structural modeling of 25B6

To model the 25B6-5-Helix interaction, we used the
FixedBBProteinDesign module in Rosetta3 using the cocrystal structure of D5 and 5-Helix as a starting model
(PDB ID 2CMR) [6,38,39]. Amino acid substitutions
were incorporated in the light chain to match the 25B6
sequence; the lowest energy structure from 200 runs is
represented in Figure 3. The following command line
options used were used: minimize_sidechains, ex1, ex2,
nstruct 200, use_input_sc, and linmem_ig 10.
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Additional file
Additional file 1: Amino acid alignment of D5 and CR6261 variable
domains; list of structures used for design of D5-Lib-II; design and
CD characterization of 6-Helix-Fd; full competitive ELISA profiles.
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